Key result
Acute coronary syndrome was associated with significantly higher intraoperative interleukin-6 levels during coronary revascularization compared to planned procedures without ACS (p<0.001).
Why the study?
To investigate the dynamics of interleukin-6 levels in the perioperative period of coronary revascularization, depending on the presence of acute coronary syndrome.
Does the presence of acute coronary syndrome increase intraoperative IL-6 levels during coronary revascularization compared to stable coronary artery disease?
Observational (n=68)
Does the presence of acute coronary syndrome increase intraoperative IL-6 levels during coronary revascularization compared to stable coronary artery disease?
Answers are grounded in this paper and cite their sources.
Perioperative IL-6 levels are significantly elevated during coronary stenting in patients with acute coronary syndrome compared to those with stable angina, correlating with disease severity.
Percutaneous x-ray endovascular angioplasty is one of the most modern methods of treatment of severe forms of cardiovascular diseases. In the pathogenesis of acute coronary syndrome, a special place is occupied by the proinflammatory reaction of the body. The main “secondary” marker is interlekin-6. The peak of its production occurs on the first day of damage and correlates with its size. The aim of the study. To investigate the dynamics of interleukin-6 level in the perioperative period of coronary revascularization, depending on the presence of acute coronary syndrome. Materials and methods. This study included 68 patients with coronary artery disease. The patients were divided into three study groups. Group 1 and 2 patients were diagnosed with ACS, and they underwent emergency stenting of coronary vessels in order to recanalize occlusion of the coronary arteries. 3rd group patients did not have ACS and they were recanalized as planned. Results. Analyzing the results of the study, we found that the highest obtained values of IL-6 were in group 1 in comparison with the group of patients who were surgically treated as planned and after stent placement, the interleukin values were 24.8 % higher in group 1 than in group 2 and almost 4 times higher in group 3 (p<0.001). When comparing groups with acute coronary syndrome, interleukin-6 indices were significantly higher by 47.4 % before surgery in group 3 and by 24.9 % after stent placement, which once again confirms the severity of patients with acute myocardial infarction. Conclusions. Intraoperatively proinflammatory interlekin-6 after coronary artery stenting tends to increase in groups with acute coronary syndrome, while in the group with stable angina, these indicators are significantly higher by 22.8 % (p <0.001). The dynamics of Il-6 levels clearly correlates with the severity of the patient's condition and increases in the presence of acute coronary syndrome, especially in the presence of acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Dziuba et al. (2020) conducted an observational in Coronary artery disease (n=68). Acute coronary syndrome vs. No acute coronary syndrome (planned recanalization) was evaluated on Intraoperative dynamics of interleukin-6 (IL-6) levels (p=<0.001). Acute coronary syndrome was associated with significantly higher intraoperative interleukin-6 levels during coronary revascularization compared to planned procedures without ACS (p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: